Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Anthony Wing-Hung Chan"

Article category

Keywords

Publication year

"Anthony Wing-Hung Chan"

Review

Steatotic liver disease

Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
Clin Mol Hepatol 2023;29(Suppl):S302-S318.
Published online November 15, 2022
DOI: https://doi.org/10.3350/cmh.2022.0329
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of diseases characterized by fatty accumulation in hepatocytes, ranging from steatosis, non-alcoholic steatohepatitis, to cirrhosis. While histopathological evaluation of liver biopsies plays a central role in the diagnosis of NAFLD, limitations such as the problem of interobserver variability still exist and active research is underway to improve the diagnostic utility of liver biopsies. In this article, we provide a comprehensive overview of the histopathological features of NAFLD, the current grading and staging systems, and discuss the present and future roles of liver biopsies in the diagnosis and prognostication of NAFLD.

Citations

Citations to this article as recorded by  Crossref logo
  • A new diphenylmethanone from Rumex crispus L. ameliorates sodium palmitate-oleate induced steatosis in HepG2 cells
    Wen-Yao Zou, Zheng-Hong Guo, Shuai Dou, Ting Xiao, Wu-de Yang
    Natural Product Research.2026; 40(13): 3936.     CrossRef
  • An electroneutral fluorescent probe for visualization of lipid droplets polarity heterogeneity and NAFLD detection
    Zhengshuai Wu, Fei Gao, Shuyu Wang, Mengqi Yan, Shuxian Cao, Junjun Liu, Xinyue Li, Guoxia Liu, Sumei Lu, Xuechen Li
    Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2026; 346: 126842.     CrossRef
  • Clinical Profile of Psoriasis Patients With Comorbid Fatty Liver and Risk Factors for Advanced Liver Fibrosis in Those With Metabolic Dysfunction–Associated Steatotic Liver Disease
    Hidenori Watabe, Tomomitsu Miyagaki, Kaori Nakajima, Ken Go, Tatsuro Okano, Takafumi Kadono
    The Journal of Dermatology.2026; 53(2): 237.     CrossRef
  • Effects of pemafibrate on liver fibrosis in patients with MASLD and hypertriglyceridemia: A 2-year retrospective observational study using MR elastography
    Hidenao Noritake, Takafumi Inoue, Takashi Yonekura, Hiroki Tamakoshi, Yuya Ida, Moe Matsumoto, Tomohiko Hanaoka, Maho Yamashita, Masahiro Umemura, Kazuyoshi Ohta, Takeshi Chida, Kazuhito Kawata
    Journal of Clinical Lipidology.2026; 20(5): 947.     CrossRef
  • Expression of caspase-8 in non-alcoholic fatty liver disease related to ligature-induced periodontitis in rats
    Felipe Rodolfo Pereira da Silva, Victor Brito Dantas Martins, Hélio Mateus Silva Nascimento, Paulo Roberto Carneiro Gomes, Nikaely Brandão Barbosa, Vinícius da Silva Caetano, Ivana Márcia Alves Diniz, Karine Duarte da Silva, Any Carolina Cardoso Guimarães
    Journal of Applied Oral Science.2026;[Epub]     CrossRef
  • Advances in Diagnostic and Therapeutic Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ryan Njeim, Omar Abureesh, Ali Sohail, Ryan Tam, Liliane Deeb
    Livers.2026; 6(3): 35.     CrossRef
  • Spatial hepatology: Decoding liver zonation for metabolic and regenerative therapeutics (Review)
    Guiqing Chen, Hongyan Jia, Kai Zhao, Chang Gao, Yue Liu, Hong Zhu, Dakai Yang, Yun Cai
    International Journal of Molecular Medicine.2026; 58(1): 1.     CrossRef
  • Alpha‑lipoic acid–loaded chitosan nanoparticles ameliorate streptozotocin‑induced diabetic liver injury via Nrf2/HO‑1 activation and TLR4/NF‑κB and JAK2/STAT1 inhibition
    Hussein Abdelaziz Abdalla, Ekramy M. Elmorsy, Najlaa M. M. Jawad, Nora Hosny, Ahmed S. Shams, Rawan Ahmed Ayaz, Manal S. Fawzy, Gehad E. Elshopakey
    Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(11): 18061.     CrossRef
  • Dapansutrile mitigates methotrexate-induced hepatotoxicity in rats: roles of inflammation, oxidative stress, pyroptosis, and autophagy
    Haider H. Motlak, Mahmoud Elshal, Marwa S. Serrya
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Glucosamine Promotes Autophagy and Attenuates Hepatic Steatosis Via O‐GlcNAcylation–Mediated Mechanisms
    Jiwon Park, Dong Yeol Kim, Quynh T. N. Nguyen, Inn‐Oc Han
    Journal of Biochemical and Molecular Toxicology.2026;[Epub]     CrossRef
  • Association of the atherogenic index of plasma and derived indicators with future risk of liver diseases and alcoholic liver disease among Chinese middle-aged and elderly adults: A nationwide cohort study
    Meng Chen, Changhong Sun, Tie-Jun Li
    Medicine.2026; 105(32): e50030.     CrossRef
  • Integrative multi-omics and machine learning identify the SPI1-METTL16-PLIN4 axis as a candidate driver of steatosis in HepG2 cells
    Zhizhou Xiao, Huawei Bian, Ying Huang
    Biochemical and Biophysical Research Communications.2026; 834: 154435.     CrossRef
  • Spatial immune niche remodeling of the neutrophil-macrophage axis inchronic liver disease
    Jian Ding, Xiang Xiong, Changming Zhang, Hongcai Fang, Shu Li
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • From Molecular Mechanisms to Clinical Strategies: A Comprehensive Overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Damian Świerczek, Maja Dreger, Jakub Jatkowski, Jakub Kancerek, Bogna Drozdzowska, Romuald Wojnicz
    International Journal of Molecular Sciences.2026; 27(17): 7825.     CrossRef
  • MiR-625-5p regulates the development of non-alcoholic fatty liver disease by targeting CCND1
    Menghua Fan, Shurui Xie, Rongfang Zhai
    Turkish Journal of Biochemistry.2026;[Epub]     CrossRef
  • Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
    Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon
    American Journal of Gastroenterology.2025; 120(2): 410.     CrossRef
  • Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase
    Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar
    Molecular and Cellular Endocrinology.2025; 595: 112404.     CrossRef
  • Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
    Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Do Child–Turcotte–Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study
    Randhall B Carteri, Claudio A Marroni, Luis F Ferreira, Letícia P Pinto, Juliana Czermainski, Cristiane V Tovo, Sabrina A Fernandes
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice
    Yu Mou, Yao Tang, Xiuyan Zheng, Xiang Liu, Xuemei Wu, Hongji Wang, Jie Zeng, Qing Rao, Yaacov Ben-David, Yanmei Li, Lei Huang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020
    Xin Liao, Song Yu, Lin Wang, Ruyue Zhang, Ke Yu
    Frontiers in Physiology.2025;[Epub]     CrossRef
  • Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats
    Karishma Naidoo, Andile Khathi
    Molecules.2025; 30(8): 1834.     CrossRef
  • Prospective Comparison of 2D-Shear Wave Elastography and Vibration-Controlled Transient Elastography in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Qingxin Li, Yanhang Gao, Dongxuan Wang, Xiaoxue Zhu, Jing Jia, Lili Liu, Huining Tian, Lishuang Wang, Yingwen Zhang, Dezhi Zhang
    Academic Radiology.2025; 32(9): 5100.     CrossRef
  • Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a
    Congcong Zhang, Lin Chen, Yuwei Jiang, Jiannan Qiu, Yiyou Lin, Guilin Ren, Fangying Xu, Jiale Xi, Zhiling Yu, Xianglu Rong, Xiaobing Dou
    International Immunopharmacology.2025; 157: 114768.     CrossRef
  • Multiple machine learning algorithms identify 13 types of cell death-critical genes in large and multiple non-alcoholic steatohepatitis cohorts
    Renao Jiang, Longfei Dai, Xinjian Xu, Zhen Zhang
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Therapeutic potential of Glycyrrhiza glabra L. extract and atorvastatin in HFD-induced MAFLD: in vitro and in vivo exploration
    Saumya Rastogi, Vishwajeet Bachhar, Vibha Joshi, Sanjay Kumar, Dharamveer Panjwani, Lakhveer Singh, Rajesh Haldhar
    3 Biotech.2025;[Epub]     CrossRef
  • Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials
    Yutong Wu, Hao Wu, Hang Yi
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Deep learning-based method for grading histopathological liver fibrosis in rodent models of metabolic dysfunction-associated steatohepatitis
    Soo Min Ko, Jae-ik Shin, Yiyu Hong, Hyunji Kim, Insuk Sohn, Ji-Young Lee, Hyo-Jeong Han, Da Som Jeong, Yerin Lee, Woo-Chan Son
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • КЛІНІКО-МОРФОЛОГІЧНІ АСПЕКТИ ПЕРВИННОГО НЕАЛКОГОЛЬНОГО СТЕАТОГЕПАТИТУ ЗА НАЯВНОСТІ КОМОРБІДНОЇ ПАТОЛОГІЇ ЖОВЧНОГО МІХУРА
    О. Ю. Фофанова, В. В. Феденько, З. Я. Гурик, Е. О. Кіндратів, І. Г. Лаб'як
    Art of Medicine.2025; : 113.     CrossRef
  • Calycosin-7-O-β-D-glucoside alleviates nonalcoholic fatty liver disease by regulating short-chain fatty acids metabolism and metabolic regulators
    Yanping Zeng, Xinrun Huang, Yuci Ma, Xiaodie Di, Zhao Li, Hebin Wang, Xiaodong Wei
    The Journal of Nutritional Biochemistry.2025; 145: 110018.     CrossRef
  • Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
    Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • Automated Detection of Non‐Alcoholic Fatty Liver Disease Using Histopathological Images: A Systematic Review
    Hamed Zamanian, Ahmad Shalbaf, Maryam Parvizi, Roohallah Alizadehsani, Ru‐San Tan, U. Rajendra Acharya
    WIREs Data Mining and Knowledge Discovery.2025;[Epub]     CrossRef
  • Polarity Prompting Vision Foundation Models for Pathology Image Analysis
    Chong Yin, Siqi Liu, Kaiyang Zhou, Vincent Wai-Sun Wong, Pong C. Yuen
    IEEE Transactions on Medical Imaging.2025; 44(11): 4579.     CrossRef
  • Matcha mitigates metabolic and inflammatory disturbances induced by high-fat-sucrose diets in rats
    Nourhan M. Abd El-Aziz, Marwa R. Elbakatoshy, Ebtehal A. Farrage, Oscar Zannou, Reza Tahergorabi, Ayman M. Khalifah, Majid Aminzare, Mohamed G. Shehata
    Journal of Functional Foods.2025; 135: 107112.     CrossRef
  • Metabolic Dysfunction-Associated Steatohepatitis in Focus: Pathogenesis, Non-Invasive Diagnostics, and Future Approaches
    Abdulrahman Ismaiel, Mhd Bashir Almonajjed, Cristina Sorina Catana, Stefan-Lucian Popa, Dan L. Dumitrascu
    Archives of Medical Research.2025; 56(8): 103350.     CrossRef
  • Occupational and lifestyle risk factors associated with metabolic fatty liver disease among university staff in Indonesia
    Mutmainnah Husaema, Lalu Muhammad Saleh, Muhammad Furqaan Naiem, Atjo Wahyu, Darmawansyah D
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • STEATOTIC LIVER DISEASE: THE IMPACT OF TEA AND COFFEE CONSUMPTION. LITERATURE REVIEW
    V.S. Rakhmetova
    Наука и здравоохранение.2025; (5(27)): 261.     CrossRef
  • Association of Stroke With Metabolic Dysfunction–Associated Fatty Liver Disease With and Without CKD
    Yuhao Li, Shouling Wu, Jingli Gao, Yijun Zhang, Yingting Zuo, Xue Tian, Shuohua Chen, Aijun Xing, Anxin Wang, Yan He
    American Journal of Kidney Diseases.2024; 83(4): 477.     CrossRef
  • Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease
    Eun Hye Lee, Ji Young Kim, Hye Ran Yang
    International Journal of Obesity.2024; 48(4): 486.     CrossRef
  • Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
    Junmin Wang, Jiacheng Li, Yugang Fu, Yingying Zhu, Liubing Lin, Yong Li
    International Journal of Molecular Medicine.2024;[Epub]     CrossRef
  • Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
    Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
    Gut and Liver.2024; 18(2): 283.     CrossRef
  • Lipid droplet detection in histopathological images using reinforcement learning
    Yoshitomi Harada, Haruto Nishida, Keiko Matsuura
    Biotechnology & Biotechnological Equipment.2024;[Epub]     CrossRef
  • Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
    Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou
    Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
  • Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
    Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
    Journal of Cellular Biochemistry.2024;[Epub]     CrossRef
  • A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice
    Rose A. Willett, Volodymyr P. Tryndyak, Jennifer M. Hughes Hanks, Lana Elkins, Suresh K. Nagumalli, Mark I. Avigan, Sharon A. Ross, Gonçalo Gamboa da Costa, Frederick A. Beland, Ivan Rusyn, Igor P. Pogribny
    Toxicology and Applied Pharmacology.2024; 491: 117046.     CrossRef
  • A peptide alleviated oxidative damages in the L02 cells and mice liver
    Gan Gao, Zhiyang Zhang, Qiheng Wang, Zhihui Xie, Bing Liu, Hongliang Huang
    Biochemical and Biophysical Research Communications.2024; 734: 150643.     CrossRef
  • Targeting long non-coding RNA H19 as a therapeutic strategy for liver disease
    Yulan Shi, Fenghua Qu, Shiyun Zeng, Xinchen Wang, Yuting Liu, Qirui Zhang, Ding Yuan, Chengfu Yuan
    Progress in Biophysics and Molecular Biology.2024; 194: 1.     CrossRef
  • Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease
    Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy
    International Journal of Biological Macromolecules.2024; 282: 137235.     CrossRef
  • Arctium lappa L. Extract Alleviates Non-Alcoholic Fatty Liver Injury in Mices
    娜 李
    Hans Journal of Medicinal Chemistry.2024; 12(04): 309.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
    Diabetes & Metabolism Journal.2024; 48(6): 1015.     CrossRef
  • Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
    Yu-Jin Zhu, Yan Zhang, Yao Rao, Yong Jiang, Yong-Gang Liu, Jian-Zhou Li, Jia-Qi Yuan, Ying Zhao, Wen-Wen Zheng, Lin Ma, Chun-Yan Wang, Jia Li
    World Journal of Hepatology.2024; 16(12): 1407.     CrossRef
  • Gut microbiome and nonalcoholic fatty liver disease
    Meng-Yuan Wu, Jian-Gao Fan
    Hepatobiliary & Pancreatic Diseases International.2023; 22(5): 444.     CrossRef
  • 18,087 View
  • 441 Download
  • 53 Web of Science
  • Crossref